Clinical Trials Directory

Trials / Completed

CompletedNCT01200511

Pilot Study of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL)

A Prospective Pilot Clinical Study of the AcrySof® IQ ReSTOR® Multifocal Toric IOL

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to describe visual outcomes, in particular spherical equivalent by manifest refraction and visual acuity across a range of distances, 6 months post implantation of the AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOL in adult patients with corneal astigmatism. Additionally, patient reported outcomes will be assessed.

Detailed description

Each subject completed a preoperative examination of both eyes, implantation of IOL at the operative visit for each eye, and up to 5 postoperative visits (each eye examined at Day 1-2, with binocular visits at Month 1, Month 3, and Month 6 after the second implantation). The second implantation generally occurred within 30 days of the first.

Conditions

Interventions

TypeNameDescription
DEVICEAcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOLMultifocal IOL with extended secondary focal point and astigmatism correction implanted for long-term use over the lifetime of the cataract patient

Timeline

Start date
2010-08-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2010-09-13
Last updated
2018-07-02
Results posted
2017-04-20

Source: ClinicalTrials.gov record NCT01200511. Inclusion in this directory is not an endorsement.

Pilot Study of AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric Intraocular Lens (IOL) (NCT01200511) · Clinical Trials Directory